{
    "ticker": "PEARQ",
    "name": "Pear Therapeutics, Inc.",
    "description": "Pear Therapeutics, Inc. is a leading digital therapeutics company focused on developing software-based solutions to treat various mental health and substance use disorders. Founded in 2013 and headquartered in Boston, Massachusetts, Pear is recognized for its innovative approach to integrating technology with therapeutic interventions. The company has developed prescription digital therapeutics, which are designed to be used alongside traditional treatments, enhancing outcomes for patients. Pear's flagship products, including reSET and reSET-O, have received FDA clearance and are aimed at improving treatment adherence and health outcomes for individuals suffering from substance use disorders. By leveraging evidence-based practices and engaging users through interactive digital platforms, Pear aims to transform the way behavioral health is treated. The company is committed to expanding its portfolio of digital solutions for a range of conditions, including anxiety and depression, and actively collaborates with healthcare providers and payers to integrate its therapeutics into existing healthcare frameworks. Pear Therapeutics is at the forefront of a new era in healthcare, focusing on personalized treatment options that utilize technology to support patient engagement and long-term success.",
    "industry": [
        "Digital Therapeutics",
        "Healthcare"
    ],
    "headquarters": "Boston, Massachusetts, USA",
    "founded": "2013",
    "website": "https://www.peartherapeutics.com",
    "ceo": "Corey McCann, M.D., Ph.D.",
    "social_media": {
        "twitter": "https://twitter.com/PearTherapeutics",
        "linkedin": "https://www.linkedin.com/company/pear-therapeutics/"
    },
    "investor_relations": "https://investors.peartherapeutics.com",
    "key_executives": [
        {
            "name": "Corey McCann, M.D., Ph.D.",
            "position": "CEO"
        },
        {
            "name": "Marissa K. J. McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Digital Therapeutics",
            "products": [
                "reSET",
                "reSET-O"
            ]
        }
    ],
    "seo": {
        "meta_title": "Pear Therapeutics, Inc. | Digital Therapeutics for Mental Health",
        "meta_description": "Explore Pear Therapeutics, Inc., a leader in digital therapeutics. Discover innovative software solutions for mental health and substance use disorders.",
        "keywords": [
            "Pear Therapeutics",
            "Digital Therapeutics",
            "Mental Health",
            "Substance Use Disorder",
            "FDA Cleared",
            "reSET",
            "reSET-O"
        ]
    },
    "faq": [
        {
            "question": "What is Pear Therapeutics known for?",
            "answer": "Pear Therapeutics is known for its digital therapeutics aimed at treating mental health and substance use disorders."
        },
        {
            "question": "Who is the CEO of Pear Therapeutics?",
            "answer": "Corey McCann, M.D., Ph.D. is the CEO of Pear Therapeutics, Inc."
        },
        {
            "question": "Where is Pear Therapeutics headquartered?",
            "answer": "Pear Therapeutics is headquartered in Boston, Massachusetts, USA."
        },
        {
            "question": "What are Pear Therapeutics' main products?",
            "answer": "Pear's main products include reSET and reSET-O, digital therapeutics for substance use disorders."
        },
        {
            "question": "When was Pear Therapeutics founded?",
            "answer": "Pear Therapeutics was founded in 2013."
        }
    ],
    "competitors": [
        "AMZN",
        "PFE",
        "NVDA"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "GOOGL",
        "TSLA"
    ]
}